Our previous studies showed an up regulation of FGD4 in prostate cancer cells exhibiting resistance to Casodex, which could be the result of down regulation of miR-17-92a miRNA cluster expression that targets FGD4 through binding to the seed sequence at the 3’UTR [32]. The gene discussed is FGD4; the disease is prostate carcinoma.